Unknown

Dataset Information

0

Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells.


ABSTRACT: Dyslipidaemias, particularly elevated plasma low-density lipoprotein cholesterol (LDL-C) levels, are major risk factors for cardiovascular disease (CVD). Besides pharmacological approaches, a nutritional strategy for CVD prevention has gained increasing attention. Among functional foods, the hypocholesterolemic properties of soy are driven by a stimulation of LDL-receptor (LDL-R) activity. To characterize the effect of two soy peptides, namely, β-conglycinin-derived YVVNPDNDEN and YVVNPDNNEN on the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), one of the key-regulators of the LDL-R. PCSK9 promoter activity (luciferase assay), PCSK9 protein expression (WB) and secretion (ELISA), PCSK9 interaction with LDL-R (binding assay) and human HepG2 cells were the objects of this investigation. Treatment with YVVNPDNNEN peptide has led to a rise in PCSK9 gene expression (90.8%) and transcriptional activity (86.4%), and to a decrement in PCSK9 intracellular and secreted protein (-42.9%) levels. YVVNPDNNEN peptide reduced the protein expression of transcriptional factor HNF1α. Most changes driven by YVVNPDNDEN peptide were not statistically significant. Neither peptide inhibited the PCSK9-LDLR interaction. Although sharing a common effect on LDL-R levels through the inhibition of 3-hydroxy-3-methylglutaryl CoA reductase activity, only the YVVNPDNNEN peptide has an additional mechanism via the downregulation of PCSK9 protein levels.

SUBMITTER: Macchi C 

PROVIDER: S-EPMC8747205 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells.

Macchi Chiara C   Greco Maria Francesca MF   Ferri Nicola N   Magni Paolo P   Arnoldi Anna A   Corsini Alberto A   Sirtori Cesare R CR   Ruscica Massimiliano M   Lammi Carmen C  

Nutrients 20211231 1


<h4>Background</h4>Dyslipidaemias, particularly elevated plasma low-density lipoprotein cholesterol (LDL-C) levels, are major risk factors for cardiovascular disease (CVD). Besides pharmacological approaches, a nutritional strategy for CVD prevention has gained increasing attention. Among functional foods, the hypocholesterolemic properties of soy are driven by a stimulation of LDL-receptor (LDL-R) activity.<h4>Aim</h4>To characterize the effect of two soy peptides, namely, β-conglycinin-derived  ...[more]

Similar Datasets

| S-EPMC4947907 | biostudies-literature
| S-EPMC2667743 | biostudies-literature
| S-EPMC4911586 | biostudies-literature
| PRJNA835335 | ENA
| S-EPMC11222478 | biostudies-literature
| S-EPMC11913382 | biostudies-literature
| S-EPMC4125719 | biostudies-literature
| S-EPMC11545662 | biostudies-literature
| S-EPMC5885408 | biostudies-literature
| S-EPMC8255832 | biostudies-literature